Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a Meta-analysis

被引:16
|
作者
Sun Qin [1 ]
Yang Gangyi [2 ]
Zhang Min [1 ]
Zhang Min [1 ]
Chen Shu [1 ]
Chen Pin [1 ]
机构
[1] Sichuan Prov Peoples Hosp, Dept Gerontol, Chengdu 610072, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing 400010, Peoples R China
关键词
Diabetic nephropathy; Renal insufficiency; Flos Abelmoschi Manihot; Meta-analysis; FLAVONOLS;
D O I
10.1016/S0254-6272(15)30003-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To assess the efficacy of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy (DN). METHODS: Articles were retrieved from PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure Database, Chinese Evidence-Based Medicine Database, and Wanfang Database. Two reviewers independently reviewed the article. Only randomized controlled trials were included and 27 were identified involving 2239 patients (1143 in the treatment group and 1096 in the control group). RESULTS: Huangshukuihua (Flos Abelmoschi Manihot) had a significant effect on renal function by improving blood urea nitrogen and serum creatinine, reducing urine protein (24-h urine protein, and urinary albumin excretion rate), and improving serum albumin level, compared with the control group. CONCLUSION: Our findings suggest that, although the bioactive ingredients and mechanism underlying renal protection are unknown, the role of Huangshukuihua (Flos Abelmoschi Manihot) in the treatment of DN deserves further investigation. (C) 2015 JTCM. All rights reserved.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [21] Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review
    Li, Rui
    Xing, Jing
    Mu, Xaojing
    Wang, Hui
    Zhang, Lei
    Zhao, Yu
    Zhang, Yu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 6275 - 6283
  • [22] Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis
    Xueling Liao
    Yan Zhu
    Chao Xue
    BMC Endocrine Disorders, 22
  • [23] Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis
    Li, Yang
    Tang, Kefu
    Zhang, Zhao
    Zhang, Ming
    Zeng, Zhen
    He, Zangdong
    He, Lin
    Wan, Chunling
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (05) : 3243 - 3252
  • [24] Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
    Magee, G. M.
    Bilous, R. W.
    Cardwell, C. R.
    Hunter, S. J.
    Kee, F.
    Fogarty, D. G.
    DIABETOLOGIA, 2009, 52 (04) : 691 - 697
  • [25] Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis
    Yang Li
    Kefu Tang
    Zhao Zhang
    Ming Zhang
    Zhen Zeng
    Zangdong He
    Lin He
    Chunling Wan
    Molecular Biology Reports, 2011, 38 : 3243 - 3252
  • [26] Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis
    Liao, Xueling
    Zhu, Yan
    Xue, Chao
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [27] Preclinical evidence of the effect of quercetin on diabetic nephropathy: A meta-analysis of animal studies
    Feng, Xiao
    Bu, Fan
    Huang, Liguo
    Xu, Weilong
    Wang, Wenbin
    Wu, Quan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 921
  • [28] Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
    G. M. Magee
    R. W. Bilous
    C. R. Cardwell
    S. J. Hunter
    F. Kee
    D. G. Fogarty
    Diabetologia, 2009, 52
  • [29] A meta-analysis examining the impact of prostaglandins on diabetic nephropathy
    Guo, Xiafei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025,
  • [30] The Effectiveness and Safety of Abelmoschus manihot in Treating IgA Nephropathy: A Systematic Review and Meta-Analysis
    Jia, Qi
    Guo, Jing
    Cai, Yuzi
    Huang, Weijun
    Zhu, Zebing
    Xia, Chenhui
    Guo, Keting
    Shang, Hongcai
    Liu, Yuning
    Liu, Weijing
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022